Peptide
Thymogen
Also known as
Thymogen peptide · Glu-Trp dipeptide · EW dipeptide
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Identity | Synthetic Glu-Trp, or oglufanide: two linked amino acids discussed for immune support and recovery. Thymalin, thymosin alpha-1 and thymulin are separate identities. |
|---|---|
| Combination names | An oral product called Thymogen Alpha-1 was described as Glu-Trp plus Vilon, without component amounts. Its reports cannot isolate Thymogen or describe every injectable product. |
Notes
Thymogen is a short synthetic peptide discussed for immune support, food-triggered symptoms and recovery. Reports include easier eating, more energy, no noticeable change and unwanted effects. Product names and mixtures overlap, so an experience with an oral combination cannot automatically describe Thymogen alone.
Two linked amino acids: glutamic acid and tryptophan. Glu-Trp, also called oglufanide, was developed from thymus-extract research. Thymalin contains multiple peptides; Thymogen is synthetic. Thymosin alpha-1 and thymulin are separate identities. Morozov and Khavinson (1997): Natural and synthetic thymic peptides as therapeutics for immune dysfunction (Animal context · Accessed 2026-09-30)
Oral “Thymogen Alpha-1” can mean a combination. The MCAS thread identifies Glu-Trp plus Lys-Glu, also called Vilon, without component amounts. A similar name does not establish equivalent contents or effects across oral and injectable products. Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up (Personal report · Accessed 2026-09-30)
Source context — Morozov and Khavinson (1997): Natural and synthetic thymic peptides as therapeutics for immune dysfunction: Originator-network paper; commercial mirror is not a new evidence origin. Animal measurements of radioactivity after hydrolysis cannot establish intact-parent human half-life or route equivalence. No human benefit claim extracted.
Source context — Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up: One unverified Russian-product account; self-selected SubQ route despite IM insert; subjective symptoms and no controlled attribution. Oral blend ingredients are the commenter's identification, not an inspected batch assay or ratio.
What people notice
| Easier eating | One SubQ user reported less food-triggered malaise and mouth/throat discomfort, alongside substantial water retention and severe constipation. |
|---|---|
| Oral combination reports | Some Thymogen/Vilon users describe more energy or less fatigue and brain fog; another noticed nothing after a week. One early responder later crashed and could not reproduce the benefit. |
| Thymus-regrowth experiment | A nine-month multi-compound self-experiment did not show benefit. Reported CT changes were disputed and cannot show that Thymogen caused shrinkage or regrowth. |
Notes
Easier eating alongside constipation and water retention. MouseGraft described less food-triggered malaise and mouth/throat discomfort, substantial water retention and severe constipation. Later hormonal symptoms and the switch back to thymosin alpha-1 belong to this same account. Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up (Personal report · Accessed 2026-09-30)
Energy and recovery from exertion. The practical appeal is having less fatigue, clearer thinking or more energy. One oral Thymogen-and-Vilon user described increased energy but could not separate the two compounds. Symptom improvement does not prove restored immune function. Bioregulator experience? Oral Thymogen with Vilon (Personal report · Accessed 2026-09-30) · Did someone actually try oral thymogen alpha? (Personal report · Accessed 2026-09-30)
Oral combination reports include nonresponse and lost benefit. One commenter noticed nothing after a week. Combat_Cuddles described two unusually good weeks with less fatigue, brain fog and post-exertion worsening, then a severe crash they thought might follow overexertion. Repeat use with BPC-157 did not reproduce the initial response. These oral-product experiences do not isolate Glu-Trp. Did someone actually try oral thymogen alpha? (Personal report · Accessed 2026-09-30)
10 mg each of three peptides in a failed self-experiment. Fight Aging! reported daily SubQ totals of Thymogen, epitalon and Vilon at 10 mg each, split into two injections 12 hours apart, plus oral melatonin 20 mg nightly. This high-dose mixture did not demonstrate benefit. Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth (Secondhand community claim · Accessed 2026-09-30)
Actual accounts do not settle one course length. The psoriasis question proposed 14 days; the responder said their use went well beyond that without giving an exact length. The failed Fight Aging! experiment used ten days every month for nine months. Thymogen for psoriasis? Anyone tested it? (Community discussion · Accessed 2026-09-30) · Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth (Secondhand community claim · Accessed 2026-09-30)
Thymus-regrowth enthusiasm met an unfavorable result. Reason's Fight Aging! report described less active thymus tissue on later CT images, without a meaningful blood-cell-ratio improvement. Commenters disputed the image interpretation. One uncontrolled mixture cannot prove Thymogen caused shrinkage, but it cannot support regrowth either. Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth (Secondhand community claim · Accessed 2026-09-30)
Source context — Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up: One unverified Russian-product account; self-selected SubQ route despite IM insert; subjective symptoms and no controlled attribution. Oral blend ingredients are the commenter's identification, not an inspected batch assay or ratio.
Source context — Bioregulator experience? Oral Thymogen with Vilon: Same username as the PeptideForum report, not an independent person; formulation and amounts unstated. A vendor-named subreddit is a commercial setting; commenter affiliation unknown.
Source context — Did someone actually try oral thymogen alpha?: Oral commercial-product identity, component quantities and formulation not verified. BPC-157 and subsequent experiments confound later history; deleted replies leave gaps. No dosing amount extracted.
Source context — Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth: One participant and four-compound exposure; qualitative CT interpretation not independently validated; commenters contest image comparison. No causal proof, established protocol or Thymogen-only effect. Earlier LongeCity outline is the same Reason source family, not corroboration.
Source context — Thymogen for psoriasis? Anyone tested it?: Plan is not completed use. Respondent's 500 mcg has no route/frequency and benefit cannot be assigned to Thymogen. Search timestamp conflicts with relative page age, so exact publication date not asserted.
Doses people talk about
| Older product charts | About 100 mcg appears across IM and nasal discussions without a reliable frequency or per-use definition. Those routes cannot be merged into one dose range. |
|---|---|
| One SubQ account | About 1.6 mg/day felt helpful after lower amounts did nothing, but brought uncomfortable hormonal symptoms. The person returned to thymosin alpha-1; per-injection division was unstated. |
| Other single reports | 250 mcg sublingually was one test followed by feeling worse. A different 500 mcg report leaves route and frequency unstated; the 0.5–1 mg/day SubQ plus GHK-Cu example was only a plan. |
| High-dose mixture | The failed self-experiment used 10 mg/day each of Thymogen, epitalon and Vilon, split into two SubQ injections 12 hours apart, plus 20 mg oral melatonin nightly. It did not establish benefit. |
Notes
About 100 mcg in older product-course talk. The retained figure spans IM and nasal product discussions without one reliable frequency or per-use definition. It belongs to regional product-chart culture, not a measured community dose range. Nasal and injectable quantities cannot be merged.
About 1.6 mg per day in one SubQ account. MouseGraft said lower amounts did nothing, while this amount helped but brought uncomfortable hormonal symptoms. The person returned to thymosin alpha-1. No per-injection division was specified. Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up (Personal report · Accessed 2026-09-30)
250 mcg sublingually in a Phoenix Rising report. Blazer95 described feeling worse soon after one test under the tongue; this was not a daily schedule. Russian Immuno-modulators, page 3: sublingual Thymogen test (Personal report · Accessed 2026-09-30)
500 mcg reported; 0.5–1 mg daily proposed elsewhere. The skin-thread responder gave 500 mcg without route or frequency. The questioner's 0.5–1 mg daily SubQ with GHK-Cu was a plan, not a completed outcome; the GHK-Cu amount was unstated. Thymogen for psoriasis? Anyone tested it? (Community discussion · Accessed 2026-09-30)
10 mg each of three peptides in a failed self-experiment. Fight Aging! reported daily SubQ totals of Thymogen, epitalon and Vilon at 10 mg each, split into two injections 12 hours apart, plus oral melatonin 20 mg nightly. This high-dose mixture did not demonstrate benefit. Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth (Secondhand community claim · Accessed 2026-09-30)
Source context — Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up: One unverified Russian-product account; self-selected SubQ route despite IM insert; subjective symptoms and no controlled attribution. Oral blend ingredients are the commenter's identification, not an inspected batch assay or ratio.
Source context — Russian Immuno-modulators, page 3: sublingual Thymogen test: Single test, no verified formulation or measured absorption; the herx and molecular-weight explanations are speculation, not validated mechanisms. Unrelated drug accounts not attributed to Thymogen.
Source context — Thymogen for psoriasis? Anyone tested it?: Plan is not completed use. Respondent's 500 mcg has no route/frequency and benefit cannot be assigned to Thymogen. Search timestamp conflicts with relative page age, so exact publication date not asserted.
Source context — Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth: One participant and four-compound exposure; qualitative CT interpretation not independently validated; commenters contest image comparison. No causal proof, established protocol or Thymogen-only effect. Earlier LongeCity outline is the same Reason source family, not corroboration.
Half-life, onset & duration
| Felt onset | One SubQ user described benefit during about a week of repeated use, without an exact first-response day. |
|---|---|
| Felt duration | No dependable single-dose benefit window is recorded. Two months of improvement with oral Thymogen/Vilon describes repeated use, with later relapse and other peptide treatment. |
| Half-life | A dependable human value is unknown here. Rat radioactivity peaking at 1–2 hours and mostly excreted within 24 hours does not measure intact Thymogen clearance in people. |
Notes
About one week in one SubQ account. MouseGraft reported benefit during repeated use; no exact first-response day was given. This does not establish a predictable onset. Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up (Personal report · Accessed 2026-09-30)
No dependable single-dose benefit window. Two months of oral Thymogen with Vilon describes a period of improvement, not the duration of one dose or proof of a lasting reset. Don't know anything about peptides, suffering from neuro Long Covid (Personal report · Accessed 2026-09-30)
Later improvement can coexist with relapse. The Thymogen-and-Vilon reporter later said exertion-triggered worsening was mostly resolved but returned with mold exposure; blood-flow problems remained. Their intervening thymosin alpha-1 course makes attribution especially uncertain. Don't know anything about peptides, suffering from neuro Long Covid (Personal report · Accessed 2026-09-30)
No dependable human half-life in the community record. The older notes give no established value for how quickly intact Thymogen leaves human blood. Dose frequency, an immediate reaction and a course lasting weeks do not measure half-life.
Rat radioactivity is not human half-life. Morozov and Khavinson's rats received 870 mcg/kg IM: radioactivity peaked at 1–2 hours; about 85% was excreted within 24 hours. Chemically broken-down samples cannot measure intact Thymogen or establish human timing. Morozov and Khavinson (1997): Natural and synthetic thymic peptides as therapeutics for immune dysfunction (Animal context · Accessed 2026-09-30)
Source context — Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up: One unverified Russian-product account; self-selected SubQ route despite IM insert; subjective symptoms and no controlled attribution. Oral blend ingredients are the commenter's identification, not an inspected batch assay or ratio.
Source context — Don't know anything about peptides, suffering from neuro Long Covid: Same author as CosmicNootropic energy comment; several compounds and subjective explanation of viral persistence. No isolated Thymogen response, amount, stop-date or single-dose duration.
Source context — Morozov and Khavinson (1997): Natural and synthetic thymic peptides as therapeutics for immune dysfunction: Originator-network paper; commercial mirror is not a new evidence origin. Animal measurements of radioactivity after hydrolysis cannot establish intact-parent human half-life or route equivalence. No human benefit claim extracted.
Cycles people discuss
| Course-chart claims | Five-to-ten-day product-style courses and broader 10–20-day bioregulator courses are separate claims. Seasonal repeats and weeks on/off do not establish one calendar. |
|---|---|
| Actual versus proposed use | A skin-thread question proposed 14 days; the responder said longer without an exact length. The failed mixture experiment used ten days each month for nine months. |
Notes
5–10 days and 10–20 days are different older course claims. The first comes from product-style writeups; the second from broader bioregulator culture. Seasonal repeats, weeks on and weeks off also appear. These are retained patterns, not a proven repeat calendar or support for indefinite use.
Actual accounts do not settle one course length. The psoriasis question proposed 14 days; the responder said their use went well beyond that without giving an exact length. The failed Fight Aging! experiment used ten days every month for nine months. Thymogen for psoriasis? Anyone tested it? (Community discussion · Accessed 2026-09-30) · Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth (Secondhand community claim · Accessed 2026-09-30)
Source context — Thymogen for psoriasis? Anyone tested it?: Plan is not completed use. Respondent's 500 mcg has no route/frequency and benefit cannot be assigned to Thymogen. Search timestamp conflicts with relative page age, so exact publication date not asserted.
Source context — Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth: One participant and four-compound exposure; qualitative CT interpretation not independently validated; commenters contest image comparison. No causal proof, established protocol or Thymogen-only effect. Earlier LongeCity outline is the same Reason source family, not corroboration.
Stacks
| Vilon | Oral Thymogen/Vilon reports cannot show which ingredient helped. The energy and two-month recovery accounts share one username and are one person's history. |
|---|---|
| Epitalon and melatonin | The failed high-dose experiment combined Thymogen, epitalon and Vilon with nightly melatonin. It does not establish Thymogen-only outcomes. |
| Other additions | Repeat oral use with BPC-157 did not reproduce one person's initial benefit. Thymogen plus GHK-Cu was a skin-thread plan, rather than a completed combination result. |
Notes
Oral “Thymogen Alpha-1” can mean a combination. The MCAS thread identifies Glu-Trp plus Lys-Glu, also called Vilon, without component amounts. A similar name does not establish equivalent contents or effects across oral and injectable products. Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up (Personal report · Accessed 2026-09-30)
More compounds make the story less clear. Thymogen appears beside Vilon, epitalon and other organ bioregulators. A stack may reflect the user's goals, but improvement cannot identify which ingredient mattered. The energy report and the two-month recovery report share the same username, Dream_Imagination_58; they are one person's history, not two independent successes. Bioregulator experience? Oral Thymogen with Vilon (Personal report · Accessed 2026-09-30) · Don't know anything about peptides, suffering from neuro Long Covid (Personal report · Accessed 2026-09-30)
10 mg each of three peptides in a failed self-experiment. Fight Aging! reported daily SubQ totals of Thymogen, epitalon and Vilon at 10 mg each, split into two injections 12 hours apart, plus oral melatonin 20 mg nightly. This high-dose mixture did not demonstrate benefit. Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth (Secondhand community claim · Accessed 2026-09-30)
Thymus-regrowth enthusiasm met an unfavorable result. Reason's Fight Aging! report described less active thymus tissue on later CT images, without a meaningful blood-cell-ratio improvement. Commenters disputed the image interpretation. One uncontrolled mixture cannot prove Thymogen caused shrinkage, but it cannot support regrowth either. Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth (Secondhand community claim · Accessed 2026-09-30)
Oral combination reports include nonresponse and lost benefit. One commenter noticed nothing after a week. Combat_Cuddles described two unusually good weeks with less fatigue, brain fog and post-exertion worsening, then a severe crash they thought might follow overexertion. Repeat use with BPC-157 did not reproduce the initial response. These oral-product experiences do not isolate Glu-Trp. Did someone actually try oral thymogen alpha? (Personal report · Accessed 2026-09-30)
500 mcg reported; 0.5–1 mg daily proposed elsewhere. The skin-thread responder gave 500 mcg without route or frequency. The questioner's 0.5–1 mg daily SubQ with GHK-Cu was a plan, not a completed outcome; the GHK-Cu amount was unstated. Thymogen for psoriasis? Anyone tested it? (Community discussion · Accessed 2026-09-30)
Source context — Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up: One unverified Russian-product account; self-selected SubQ route despite IM insert; subjective symptoms and no controlled attribution. Oral blend ingredients are the commenter's identification, not an inspected batch assay or ratio.
Source context — Bioregulator experience? Oral Thymogen with Vilon: Same username as the PeptideForum report, not an independent person; formulation and amounts unstated. A vendor-named subreddit is a commercial setting; commenter affiliation unknown.
Source context — Don't know anything about peptides, suffering from neuro Long Covid: Same author as CosmicNootropic energy comment; several compounds and subjective explanation of viral persistence. No isolated Thymogen response, amount, stop-date or single-dose duration.
Source context — Reason: Reporting on a Study of One with Khavinson Peptides and Melatonin for Thymic Regrowth: One participant and four-compound exposure; qualitative CT interpretation not independently validated; commenters contest image comparison. No causal proof, established protocol or Thymogen-only effect. Earlier LongeCity outline is the same Reason source family, not corroboration.
Source context — Did someone actually try oral thymogen alpha?: Oral commercial-product identity, component quantities and formulation not verified. BPC-157 and subsequent experiments confound later history; deleted replies leave gaps. No dosing amount extracted.
Source context — Thymogen for psoriasis? Anyone tested it?: Plan is not completed use. Respondent's 500 mcg has no route/frequency and benefit cannot be assigned to Thymogen. Search timestamp conflicts with relative page age, so exact publication date not asserted.
Watch for
| Unwanted effects | Water retention, severe constipation and later uncomfortable hormonal symptoms belong to one SubQ account. Feeling worse after a sublingual test did not show that an infection was clearing. |
|---|---|
| Nasal-product warnings | The saved leaflet lists allergic rhinitis, insufficient pregnancy/breastfeeding data and a warning against high-dose glucocorticoid combinations. It cannot establish safety for other forms. |
| Quality and long-term uncertainty | Allergy, impurities and injection-site reactions remain concerns. Saved cautions call for medical care for severe allergic symptoms, chest pain or neurological changes. |
Notes
Easier eating alongside constipation and water retention. MouseGraft described less food-triggered malaise and mouth/throat discomfort, substantial water retention and severe constipation. Later hormonal symptoms and the switch back to thymosin alpha-1 belong to this same account. Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up (Personal report · Accessed 2026-09-30)
Worsening does not prove benefit. Blazer95's “herx” explanation was speculation; the reaction cannot verify absorption or infection clearance. Russian Immuno-modulators, page 3: sublingual Thymogen test (Personal report · Accessed 2026-09-30)
Pregnancy, breastfeeding and medicines need separate attention. Cytomed's nasal leaflet reports insufficient pregnancy and breastfeeding data, warns against combination with high-dose glucocorticoids, and lists allergic rhinitis. Those product-specific warnings cannot establish safety for other forms, autoimmune illness or research products. Cytomed Timogen nasal-spray instructions (Official context · Accessed 2026-09-30)
Product identity and long-term safety remain uncertain. The existing cautions include allergy, impurities, injection-site redness, itching, lumps and bruising. Mixtures make reactions harder to assign. Severe allergic reactions, chest pain, neurological changes or uncontrolled blood pressure or glucose require medical care. Storage is formulation-specific; a general forum rule cannot cover every product.
Source context — Thymogen alpha-1: MouseGraft's Russian injectable account and follow-up: One unverified Russian-product account; self-selected SubQ route despite IM insert; subjective symptoms and no controlled attribution. Oral blend ingredients are the commenter's identification, not an inspected batch assay or ratio.
Source context — Russian Immuno-modulators, page 3: sublingual Thymogen test: Single test, no verified formulation or measured absorption; the herx and molecular-weight explanations are speculation, not validated mechanisms. Unrelated drug accounts not attributed to Thymogen.
Source context — Cytomed Timogen nasal-spray instructions: Russian-language manufacturer leaflet with promotional surroundings; product-specific labeling is not independent effectiveness evidence and cannot validate research-chemical routes. No article dose schedule derived from this official source.
Full notes
Thymogen is a short synthetic peptide discussed for immune support, food-triggered symptoms and recovery. Reports include easier eating, more energy, no noticeable change and unwanted effects. Product names and mixtures overlap, so an experience with an oral combination cannot automatically describe Thymogen alone.
What Thymogen actually is
- Two linked amino acids: glutamic acid and tryptophan. Glu-Trp, also called oglufanide, was developed from thymus-extract research. Thymalin contains multiple peptides; Thymogen is synthetic. Thymosin alpha-1 and thymulin are separate identities. Animal context Community
- Oral “Thymogen Alpha-1” can mean a combination. The MCAS thread identifies Glu-Trp plus Lys-Glu, also called Vilon, without component amounts. A similar name does not establish equivalent contents or effects across oral and injectable products. Personal report
What people hope to improve
- Energy and recovery from exertion. The practical appeal is having less fatigue, clearer thinking or more energy. One oral Thymogen-and-Vilon user described increased energy but could not separate the two compounds. Symptom improvement does not prove restored immune function. Personal report Personal report
- Skin complaints and immune “normalization.” In a psoriasis thread, a commenter associated several thymus peptides with improved eczema and other autoimmune complaints. They did not isolate Thymogen. The older immune-support story does not demonstrate an organ-only effect or guaranteed benefit; subtle recovery feelings can also overlap with changes in sleep or diet. Reddit r/peptidebioregulators Community
Doses people discuss
These are reports and circulated amounts, not instructions. 1,000 mcg equals 1 mg. SubQ means beneath the skin; IM means into muscle.
- About 100 mcg in older product-course talk. The retained figure spans IM and nasal product discussions without one reliable frequency or per-use definition. It belongs to regional product-chart culture, not a measured community dose range. Nasal and injectable quantities cannot be merged. Community
- About 1.6 mg per day in one SubQ account. MouseGraft said lower amounts did nothing, while this amount helped but brought uncomfortable hormonal symptoms. The person returned to thymosin alpha-1. No per-injection division was specified. Personal report
- 250 mcg sublingually in a Phoenix Rising report. Blazer95 described feeling worse soon after one test under the tongue; this was not a daily schedule. Personal report
- 500 mcg reported; 0.5–1 mg daily proposed elsewhere. The skin-thread responder gave 500 mcg without route or frequency. The questioner's 0.5–1 mg daily SubQ with GHK-Cu was a plan, not a completed outcome; the GHK-Cu amount was unstated. Reddit r/peptidebioregulators
- 10 mg each of three peptides in a failed self-experiment. Fight Aging! reported daily SubQ totals of Thymogen, epitalon and Vilon at 10 mg each, split into two injections 12 hours apart, plus oral melatonin 20 mg nightly. This high-dose mixture did not demonstrate benefit. Fight Aging! user-created longevity blog
Half-life
- No dependable human half-life in the community record. The older notes give no established value for how quickly intact Thymogen leaves human blood. Dose frequency, an immediate reaction and a course lasting weeks do not measure half-life. Community
Onset: when a change is noticed
- About one week in one SubQ account. MouseGraft reported benefit during repeated use; no exact first-response day was given. This does not establish a predictable onset. Personal report
Duration: how long a change lasts
- No dependable single-dose benefit window. Two months of oral Thymogen with Vilon describes a period of improvement, not the duration of one dose or proof of a lasting reset. Personal report
- Later improvement can coexist with relapse. The Thymogen-and-Vilon reporter later said exertion-triggered worsening was mostly resolved but returned with mold exposure; blood-flow problems remained. Their intervening thymosin alpha-1 course makes attribution especially uncertain. Personal report
Cycles and breaks
- 5–10 days and 10–20 days are different older course claims. The first comes from product-style writeups; the second from broader bioregulator culture. Seasonal repeats, weeks on and weeks off also appear. These are retained patterns, not a proven repeat calendar or support for indefinite use. Community
- Actual accounts do not settle one course length. The psoriasis question proposed 14 days; the responder said their use went well beyond that without giving an exact length. The failed Fight Aging! experiment used ten days every month for nine months. Reddit r/peptidebioregulators Fight Aging! user-created longevity blog
Cautions that matter
- Worsening does not prove benefit. Blazer95's “herx” explanation was speculation; the reaction cannot verify absorption or infection clearance. Personal report
- Pregnancy, breastfeeding and medicines need separate attention. Cytomed's nasal leaflet reports insufficient pregnancy and breastfeeding data, warns against combination with high-dose glucocorticoids, and lists allergic rhinitis. Those product-specific warnings cannot establish safety for other forms, autoimmune illness or research products. Official context
- Product identity and long-term safety remain uncertain. The existing cautions include allergy, impurities, injection-site redness, itching, lumps and bruising. Mixtures make reactions harder to assign. Severe allergic reactions, chest pain, neurological changes or uncontrolled blood pressure or glucose require medical care. Storage is formulation-specific; a general forum rule cannot cover every product. Community
What the animal timing study measured
- Rat radioactivity is not human half-life. Morozov and Khavinson's rats received 870 mcg/kg IM: radioactivity peaked at 1–2 hours; about 85% was excreted within 24 hours. Chemically broken-down samples cannot measure intact Thymogen or establish human timing. Animal context
How the experiences fit together
- Easier eating alongside constipation and water retention. MouseGraft described less food-triggered malaise and mouth/throat discomfort, substantial water retention and severe constipation. Later hormonal symptoms and the switch back to thymosin alpha-1 belong to this same account. Personal report
- Oral combination reports include nonresponse and lost benefit. One commenter noticed nothing after a week. Combat_Cuddles described two unusually good weeks with less fatigue, brain fog and post-exertion worsening, then a severe crash they thought might follow overexertion. Repeat use with BPC-157 did not reproduce the initial response. These oral-product experiences do not isolate Glu-Trp. Personal report
- Thymus-regrowth enthusiasm met an unfavorable result. Reason's Fight Aging! report described less active thymus tissue on later CT images, without a meaningful blood-cell-ratio improvement. Commenters disputed the image interpretation. One uncontrolled mixture cannot prove Thymogen caused shrinkage, but it cannot support regrowth either. Fight Aging! user-created longevity blog
- More compounds make the story less clear. Thymogen appears beside Vilon, epitalon and other organ bioregulators. A stack may reflect the user's goals, but improvement cannot identify which ingredient mattered. The energy report and the two-month recovery report share the same username, Dream_Imagination_58; they are one person's history, not two independent successes. Personal report Personal report Community
